NuMedii

8 articles about NuMedii

• NuMedii Announces Creation of World's First Single-Cell Sequencing Atlas for Idiopathic Pulmonary Fibrosis by its Collaborators

  7/9/2020

  NuMedii, Inc., a data-driven drug discovery company, today announced the availability of the world's first single-cell sequencing atlas for idiopathic pulmonary fibrosis (IPF) that was the result of a strategic research collaboration including the Yale School of Medicine, Baylor College of Medicine, Brigham and Women's Hospital, and NuMedii.

• NuMedii, Inc. Announces Pharmaceutical Discovery Collaboration For Ulcerative Colitis

  1/15/2020

  NuMedii, Inc. today announced a new partnership with a drug delivery company to develop new therapeutics for ulcerative colitis

• NuMedii Announces Research Collaboration With Leading Academic Research Institution to Explore New Targets and Therapeutics for Pancreatitis

  11/1/2018

  The collaboration brings together deep clinical expertise with NuMedii's Artificial Intelligence Drug Discovery technology, which will enable the discovery of novel targets and precision drug candidates for both acute and chronic forms of the disease.

• NuMedii Names Industry Veteran Heather Arnett, Ph.D. as Vice President of Research

  11/1/2018

  NuMedii, Inc., today announced the appointment of Heather Arnett, Ph.D., as Vice President, Research.

• NuMedii Announces Strategic Research Collaboration with Two Leading Academic Research Institutions Utilizing Single-Cell Sequencing to Identify Precision Therapeutics for IPF

  7/10/2018

  NuMedii, Inc., today announced the formation of a strategic research collaboration with Yale School of Medicine and Brigham and Women's Hospital

• World's Leading Lung Disease Experts Join NuMedii’s Idiopathic Pulmonary Fibrosis Advisory Board

  1/9/2018

  The newly formed Board of Advisors will provide deep scientific and clinical expertise to the company as it discovers and advances new treatments for IPF based on NuMedii's AIDD technology.

• NuMedii Announces New Partnership To Discover And Advance New Treatments For Idiopathic Pulmonary Fibrosis

  4/11/2017

• NuMedii Announces Third Pharmaceutical Discovery Collaboration

  10/4/2016